Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 11
Judge Sets Trial for May 31, Orders Production of Five Merck Witnesses
Louisiana Woman Files Bextra Personal Injury Class Action
MDL Court Appoints Liaison Counsel as Nearly 100 Apply for Steering Spots
Merck Moves to Vacate Award of Attorneys' Fees in Jurisdictional Dispute
New Jersey Judge Issues Orders on Discovery Items, Economic Damage Claims
Pfizer: Celebrex Heart Attack Claimant Fraudulently Joined Doctor, Sales Rep
South Carolina Man Suffered Celebrex-Related Heart Attack, Complaint Alleges
Judge Remands Vioxx Case, Finds Aggregation Improper
